Abstract The clinical responses observed following treatment with immune checkpoint inhibitors (ICIs) support immunotherapy as a potential anticancer treatment. However, a large proportion of patients cannot benefit from it due to resistance or relapse, which is most likely attributable to the multi...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!